40050 Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–15792 Filed 7–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–0800; Docket No. CDC–2021– 

0072] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Focus Group Testing to Effectively 

Plan and Tailor Cancer Prevention and 

Control Communication Campaigns. 

CDC is requesting a Revision to this 

Generic Clearance to include an 

additional cancer-related 

communications campaign, expand the 

modes of data collection to include 

online focus groups and in-depth 

interviews (in-person, phone, and 

online), and to focus on respondents 

from the general public. 

DATES: CDC must receive written 

comments on or before September 24, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0072 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Focus Group Testing to Effectively 

Plan and Tailor Cancer Prevention and 

Control Communications Campaigns— 

(OMB Control No. 0920–0800, Exp. 10/ 

31/2021)—Revision—National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The mission of the CDC’s Division of 

Cancer Prevention and Control (DCPC) 

is to reduce the burden of cancer in the 

United States through cancer 

prevention, reduction of risk, early 

detection, and improved quality of life 

for cancer survivors. Toward this end, 

the DCPC supports the scientific 

development and implementation of 

various health communication 

campaigns with an emphasis on specific 

cancer burdens. 

This process requires testing of 

messages, concepts, and materials prior 

to their final development and 

dissemination, as described in the 

second step of the health 

communication process. The health 

communication process is a scientific 

model developed by the U.S. 

Department of Health and Human 

Services’ National Cancer Institute to 

guide sound campaign development. 

The communication literature supports 

various data collection methods to 

conduct credible formative, concept, 

message, and materials testing. This 

process ensures that the public clearly 

understands cancer-specific information 

and concepts, are motivated to take the 

desired action, and do not react 

negatively to the messages. CDC is 

currently approved to collect 

information needed to plan and tailor 

cancer communication campaigns (OMB 

Control No. 0920–0800, Exp. 10/31/ 

2021), and seeks OMB approval to 

revise the existing generic clearance to 

include another cancer-related 

communications campaign, expand the 

modes of data collection to include 

online focus groups and in-depth 

interviews (in-person, phone, and 

online), and to focus on respondents 

from the general public. 

Information collection will involve 

discussions to assess numerous 

qualitative dimensions of cancer 

prevention and control messages 

including, but not limited to, cancer 

knowledge, attitudes, beliefs, behavioral 

intentions, information needs and 

sources, and compliance with cancer 

screening as recommended by the 

United States Preventive Services Task 

Force. Insights gained from these 

discussions will assist in the 

development and/or refinement of 

future campaign messages and 

materials. Communication campaigns 

and messages will vary according to the 

type of cancer and the qualitative 

dimensions of the message described 

above. A separate information collection 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 40051 

request will be submitted to OMB for 

approval of each discussion activity. 

The request will describe the purpose of 

the activity and include the customized 

information collection instruments. 

OMB approval is requested for three 

years. There is no change in burden 

hours or respondents. Participation is 

voluntary and there are no costs to 

respondents except their time. CDC 

requests approval for an estimated 1,680 

annual burden hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

General Public .................................. Screening Form ................................ 1600 1 3/60 80 

General Public .................................. Discussion Guide ............................. 800 1 2 1,600 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,680 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–15795 Filed 7–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Mine Safety and Health Research 

Advisory Committee (MSHRAC); 

Cancellation of Meeting 

Notice is hereby given of a change in 

the meeting of the Mine Safety and 

Health Research Advisory Committee 

(MSHRAC); June 21, 2021, 10:00 a.m.– 

2:30 p.m., EDT, in the original FRN. 

The meeting was published in the 

Federal Register on April 23, 2021, 

Volume 86, Number 77, page 21739. 

This meeting is being canceled in its 

entirety. 

FOR FURTHER INFORMATION CONTACT: 

George W. Luxbacher, Designated 

Federal Officer, MSHRAC, National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention, 2400 Century Parkway NE, 

Atlanta, GA 30345; Telephone: (404) 

498–2808; email: gluxbacher@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–15800 Filed 7–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–0556] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Assisted 

Reproductive Technology (ART) 

Program Reporting System’’ to the 

Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on March 12, 2021 to obtain 

comments from the public and affected 

agencies. CDC did not receive comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Assisted Reproductive Technology 

(ART) Program Reporting System (OMB 

Control No. 0920–0556, Exp. 8/31/ 

2021)—Revision—National Center for 

Chronic Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 


jbell on DSKJLSW7X2PROD with NOTICES